New lab-made compounds slow the growth of cancer cells in a dish
Original title: Unveiling acetamide coupled benzothiazole hydrazones as potential anti-proliferative agents: an experimental and computational approach.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done on cells in a dish and in computer models, not in people.
The short version
Scientists built a group of new chemicals and found that a few of them killed cancer cells in the lab, including brain tumor cells.
What was studied. Researchers made a series of new compounds called benzothiazole acetamide hydrazones. They tested them on human cancer cells grown in a dish, including glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells (LN229), plus pancreatic, colon, leukemia, lung, and lymphoblast cell lines.
What they found. Three of the compounds, called 8l, 8n, and 8o, stood out. They killed cells from more than one kind of cancer. Compound 8o worked most strongly on the Z138 and LN229 cell lines. Computer models suggested that 8o and 8n stick well to a protein called topoisomerase II, which cancer cells use to copy their DNA.
What this means, and what it doesn't
What it could mean: This is a starting point. It tells chemists which of these new compounds are worth studying further. Any of this could take many years to become a treatment, and most compounds at this stage never do.
What it doesn't mean: This does not mean there is a new brain tumor treatment. The work was done on cells in a dish and on a computer. No person was given any of these compounds. It has not been tested in animals or in people, so nothing is known about whether it is safe or whether it helps a patient live longer. This is not a cure and is not a promise of one. Do not change your care based on this study.
Source: PubMed, July 6, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.